Seizing on an imaging technology that allows scientists to identify individual small molecules, the labs have for the first time mapped metabolites in two organs at high spatial resolution, tracking their metabolic fate in the small intestine and the liver.

In partnership with the DOD, the Weichman Lab will investigate polaritons and how to use visible light as a “control knob” to one day direct molecular behavior.

Photoredox catalysis–research funded by the NIH–has spurred a throng of new drug therapies, fine chemicals, agrobusiness products, and fragrance applications throughout the U.S. and the world.